HIV Neurotoxicity: Potential Therapeutic Interventions

Wallace, David R.

doi:https://doi.org/10.1155/JBB/2006/65741

BioMed Research International

On this page

Abstract References Copyright Related Articles

Special Issue

Neurodegenerative Diseases: Mechanisms and Therapies

View this Special Issue

Review Article | Open Access

Volume 2006 | Article ID 065741 | https://doi.org/10.1155/JBB/2006/65741

HIV Neurotoxicity: Potential Therapeutic Interventions

David R. Wallace¹

Received01 Dec 2005

Revised21 Feb 2006

Accepted27 Feb 2006

Published29 Mar 2006

Abstract

Individuals suffering from human immunodeficiency virus type 1 (HIV-1) infection suffer from a wide range of neurological deficits. The most pronounced are the motor and cognitive deficits observed in many patients in the latter stages of HIV infection. Gross postmortem inspection shows cortical atrophy and widespread neuronal loss. One of the more debilitating of the HIV-related syndromes is AIDS-related dementia, or HAD. Complete understanding of HIV neurotoxicity has been elusive. Both direct and indirect toxic mechanisms have been implicated in the neurotoxicity of the HIV proteins, Tat and gp120. The glutamatergic system, nitric oxide, calcium, oxidative stress, apoptosis, and microglia have all been implicated in the pathogenesis of HIV-related neuronal degeneration. The aim of this review is to summarize the most recent work and provide an overview to the current theories of HIV-related neurotoxicity and potential avenues of therapeutic interventions to prevent the neuronal loss and motor/cognitive deficits previously described.

References

B A Bennett, D E Rusyniak, and C K Hollingsworth, “HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures,” Brain Research, vol. 705, no. 1-2, pp. 168–176, 1995.
View at: Google Scholar
A Nath, K Psooy, C Martin et al., “Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic,” Journal of Virology, vol. 70, no. 3, pp. 1475–1480, 1996.
View at: Google Scholar
J Cheng, A Nath, B Knudsen et al., “Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein,” Neuroscience, vol. 82, no. 1, pp. 97–106, 1998.
View at: Google Scholar
M Y Aksenov, U Hasselrot, A K Bansal et al., “Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum,” Neuroscience Letters, vol. 305, no. 1, pp. 5–8, 2001.
View at: Google Scholar
A K Bansal, C F Mactutus, A Nath et al., “Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum,” Brain Research, vol. 879, no. 1-2, pp. 42–49, 2000.
View at: Google Scholar
M Y Aksenov, U Hasselrot, G Wu et al., “Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum,” Brain Research, vol. 987, no. 1, pp. 1–9, 2003.
View at: Google Scholar
II Kruman, A Nath, and M P Mattson, “HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress,” Experimental Neurology, vol. 154, no. 2, pp. 276–288, 1998.
View at: Google Scholar
E S Gavriil, R Cooney, and B S Weeks, “Tat mediates apoptosis in vivo in the rat central nervous system,” Biochemical and Biophysical Research Communications, vol. 267, no. 1, pp. 252–256, 2000.
View at: Google Scholar
N J Haughey, C P Holden, A Nath et al., “Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat,” Journal of Neurochemistry, vol. 73, no. 4, pp. 1363–1374, 1999.
View at: Google Scholar
D R New, S B Maggirwar, L G Epstein et al., “HIV-1 Tat induces neuronal death via tumor necrosis factor- $\alpha$ and activation of non-N-methyl-D-aspartate receptors by a NF $\kappa$ B-independent mechanism,” The Journal of Biological Chemistry, vol. 273, no. 28, pp. 17852–17858, 1998.
View at: Google Scholar
A Nath, N J Haughey, M Jones et al., “Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine,” Annals of Neurology, vol. 47, no. 2, pp. 186–194, 2000.
View at: Google Scholar
E Polazzi, G Levi, and L Minghetti, “Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 8, pp. 825–831, 1999.
View at: Google Scholar
G Bagetta, M T Corasaniti, A M Paoletti et al., “HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2),” Biochemical and Biophysical Research Communications, vol. 244, no. 3, pp. 819–824, 1998.
View at: Google Scholar
M C Yeung, F Geertsma, J Liu et al., “Inhibition of HIV-1 gp120-induced apoptosis in neuroblastoma SK-N-SH cells by an antisense oligodeoxynucleotide against p53,” AIDS, vol. 12, no. 4, pp. 349–354, 1998.
View at: Google Scholar
J Raber, S M Toggas, S Lee et al., “Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase,” Virology, vol. 226, no. 2, pp. 362–373, 1996.
View at: Google Scholar
N Sacktor, N Haughey, R Cutler et al., “Novel markers of oxidative stress in actively progressive HIV dementia,” Journal of Neuroimmunology, vol. 157, no. 1-2, pp. 176–184, 2004.
View at: Google Scholar
A Perl and K Banki, “Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease,” Antioxidants & Redox Signaling, vol. 2, no. 3, pp. 551–573, 2000.
View at: Google Scholar
N J Haughey and M P Mattson, “Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120,” Journal of Acquired Immune Deficiency Syndromes, vol. 31, no. suppl 2, pp. S55–S61, 2002.
View at: Google Scholar
A Nath, “Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia,” The Journal of Infectious Diseases, vol. 186, no. suppl 2, pp. S193–S198, 2002.
View at: Google Scholar
A Minagar, P Shapshak, R Fujimura et al., “The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis,” Journal of the Neurological Sciences, vol. 202, no. 1-2, pp. 13–23, 2002.
View at: Google Scholar
G A Garden, W Guo, S Jayadev et al., “HIV associated neurodegeneration requires p53 in neurons and microglia,” The FASEB Journal, vol. 18, no. 10, pp. 1141–1143, 2004.
View at: Google Scholar
A J Bruce-Keller, A Chauhan, F O Dimayuga et al., “Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain,” The Journal of Neuroscience, vol. 23, no. 23, pp. 8417–8422, 2003.
View at: Google Scholar
A Chauhan, J Turchan, C Pocernich et al., “Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 13512–13519, 2003.
View at: Google Scholar
B Y Zhou, Y Liu, B Kim et al., “Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes,” Molecular and Cellular Neuroscience, vol. 27, no. 3, pp. 296–305, 2004.
View at: Google Scholar
V K Khurdayan, S Buch, N El-Hage et al., “Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro,” European Journal of Neuroscience, vol. 19, no. 12, pp. 3171–3182, 2004.
View at: Google Scholar
S D Mahajan, R Aalinkeel, J L Reynolds et al., “Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells,” Current HIV Research , vol. 3, no. 3, pp. 277–288, 2005.
View at: Google Scholar
M V Catani, M T Corasaniti, M Ranalli et al., “The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells,” Journal of Neurochemistry, vol. 84, no. 6, pp. 1237–1245, 2003.
View at: Google Scholar
V Pandey and S R Bolsover, “Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor,” Biochemical and Biophysical Research Communications, vol. 274, no. 1, pp. 212–215, 2000.
View at: Google Scholar
M Kaul and S A Lipton, “Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 14, pp. 8212–8216, 1999.
View at: Google Scholar
J Zheng, M R Thylin, A Ghorpade et al., “Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia,” Journal of Neuroimmunology, vol. 98, no. 2, pp. 185–200, 1999.
View at: Google Scholar
V J Sanders, I P Everall, R W Johnson et al., “Fibroblast growth factor modulates co-receptor CXCR4 expression by neural cells. HNRC {Group},” Journal of Neuroscience Research, vol. 59, no. 5, pp. 671–679, 2000.
View at: Google Scholar
M V Catani, M T Corasaniti, M Navarra et al., “Gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors,” Journal of Neurochemistry, vol. 74, no. 6, pp. 2373–2379, 2000.
View at: Google Scholar
P Bezzi, M Domercq, L Brambilla et al., “CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity,” Nature Neuroscience, vol. 4, no. 7, pp. 702–710, 2001.
View at: Google Scholar
F Noorbakhsh, N Vergnolle, J C McArthur et al., “Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection,” Journal of Immunology, vol. 174, no. 11, pp. 7320–7329, 2005.
View at: Google Scholar
M Z Khan, S Shimizu, J P Patel et al., “Regulation of neuronal P53 activity by CXCR 4,” Molecular and Cellular Neurosciences, vol. 30, no. 1, pp. 58–66, 2005.
View at: Google Scholar
A Bachis and I Mocchetti, “The chemokine receptor CXCR4 and not the N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells,” Journal of Neuroscience Research, vol. 75, no. 1, pp. 75–82, 2004.
View at: Google Scholar
Z G Jiang, C Piggee, M P Heyes et al., “Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages,” Journal of Neuroimmunology, vol. 117, no. 1-2, pp. 97–107, 2001.
View at: Google Scholar
S M Toggas, E Masliah, and L Mucke, “Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine,” Brain Research, vol. 706, no. 2, pp. 303–307, 1996.
View at: Google Scholar
P Wu, P Price, B Du et al., “Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons,” Neuroreport, vol. 7, no. 5, pp. 1045–1049, 1996.
View at: Google Scholar
S Vesce, P Bezzi, D Rossi et al., “HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid,” FEBS Letters, vol. 411, no. 1, pp. 107–109, 1997.
View at: Google Scholar
C P Holden, N J Haughey, A Nath et al., “Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated ${\text{Ca}}^{2 + }$ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular ${\text{Ca}}^{2 + }$ in human neurons and astrocytes,” Neuroscience, vol. 91, no. 4, pp. 1369–1378, 1999.
View at: Google Scholar
A Perez, A W Probert, K K Wang et al., “Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture,” Journal of Neurovirology, vol. 7, no. 1, pp. 1–10, 2001.
View at: Google Scholar
D G Smith, G J Guillemin, L Pemberton et al., “Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat,” Journal of Neurovirology, vol. 7, no. 1, pp. 56–60, 2001.
View at: Google Scholar
K J Swartz, M J During, A Freese et al., “Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors,” The Journal of Neuroscience, vol. 10, no. 9, pp. 2965–2973, 1990.
View at: Google Scholar
G Gras, F Chretien, A V Vallat-Decouvelaere et al., “Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection?” Brain Pathology, vol. 13, no. 2, pp. 211–222, 2003.
View at: Google Scholar
T Chandra, W Maier, H G Konig et al., “Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits,” Neuroscience, vol. 134, no. 1, pp. 145–153, 2005.
View at: Google Scholar
K M Boje, “Nitric oxide neurotoxicity in neurodegenerative diseases,” Frontiers in Bioscience, vol. 9, pp. 763–776, 2004.
View at: Google Scholar
G Bagetta, S Piccirilli, C Del Duca et al., “Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat,” Neuroscience Letters, vol. 356, no. 3, pp. 183–186, 2004.
View at: Google Scholar
A Scorziello, T Florio, A Bajetto et al., “TGF-beta1 prevents gp120-induced impairment of ${\text{Ca}}^{2 + }$ homeostasis and rescues cortical neurons from apoptotic death,” Journal of Neuroscience Research, vol. 49, no. 5, pp. 600–607, 1997.
View at: Google Scholar
B Shi, J Raina, A Lorenzo et al., “Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia,” Journal of Neurovirology, vol. 4, no. 3, pp. 281–290, 1998.
View at: Google Scholar
W Chen, J Sulcove, I Frank et al., “Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway,” Journal of Virology, vol. 76, no. 18, pp. 9407–9419, 2002.
View at: Google Scholar
L A Ryan, H Peng, D A Erichsen et al., “TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia,” Journal of Neuroimmunology, vol. 148, no. 1-2, pp. 127–139, 2004.
View at: Google Scholar
M T Corasaniti, C Bellizzi, R Russo et al., “Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells,” Toxicology Letters, vol. 139, no. 2-3, pp. 213–219, 2003.
View at: Google Scholar
E Acquas, A Bachis, R L Nosheny et al., “Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases,” Neurotoxicity Research, vol. 5, no. 8, pp. 605–615, 2004.
View at: Google Scholar
I N Singh, R J Goody, C Dean et al., “Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: differential involvement of caspase-3 and endonuclease G,” Journal of Neurovirology, vol. 10, no. 3, pp. 141–151, 2004.
View at: Google Scholar
R A Clark and R Bessinger, “Clinical manifestations and predictors of survival in older women infected with HIV,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 15, no. 5, pp. 341–345, 1997.
View at: Google Scholar
L S Schneider, “Estrogen and dementia: insights from the woman's health initiative memory study,” The Journal of the American Medical Association, vol. 291, no. 24, pp. 3005–3007, 2004.
View at: Google Scholar
P S Green and J W Simpkins, “Neuroprotective effects of estrogens: potential mechanisms of action,” International Journal of Developmental Neuroscience, vol. 18, no. 4-5, pp. 347–358, 2000.
View at: Google Scholar
L M Garcia-Segura, I Azcoitia, and L L DonCarlos, “Neuroprotection by estradiol,” Progress in Neurobiology, vol. 63, no. 1, pp. 29–60, 2001.
View at: Google Scholar
P S Green, K Gordon, and J W Simpkins, “Phenolic A ring requirement for the neuroprotective effects of steroids,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 63, no. 4–6, pp. 229–235, 1997.
View at: Google Scholar
S M Smith, G B Baskin, and P A Marx, “Estrogen protects against vaginal transmission of simian immunodeficiency virus,” The Journal of Infectious Diseases, vol. 182, no. 3, pp. 708–715, 2000.
View at: Google Scholar
J Turchan, C Anderson, K F Hauser et al., “Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine,” BMC Neuroscience, vol. 2, p. 3, 2001.
View at: Google Scholar
Y W Lee, S Y Eum, A Nath et al., “Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells,” Cardiovascular Research, vol. 63, no. 1, pp. 139–148, 2004.
View at: Google Scholar
V Hawkins, Q Shen, and C C Chiueh, “Kynostatin and 17beta-estradio prevent the apoptotic death of human neuroblastoma cells exposed to HIV-1 protease,” Journal of Biomedical Science, vol. 6, no. 6, pp. 433–438, 1999.
View at: Google Scholar
S L Kendall, C F Anderson, A Nath et al., “Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism,” BMC Neuroscience, vol. 6, no. 1, p. 40, 2005.
View at: Google Scholar
M T Corasaniti, D Amantea, R Russo et al., “17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat,” Neurotoxicology, vol. 26, no. 5, pp. 893–903, 2005.
View at: Google Scholar
S M Brooke and R M Sapolsky, “The effects of steroid hormones in HIV-related neurotoxicity: a mini review,” Biological Psychiatry, vol. 48, no. 9, pp. 881–893, 2000.
View at: Google Scholar
S Brooke, R Chan, S Howard et al., “Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 17, pp. 9457–9462, 1997.
View at: Google Scholar
A M Iyer, S M Brooke, and R M Sapolsky, “Glucocorticoids interact with gp120 in causing neurotoxicity in striatal cultures,” Brain Research, vol. 808, no. 2, pp. 305–309, 1998.
View at: Google Scholar
A Yusim, L Franklin, S Brooke et al., “Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants,” Journal of Neurochemistry, vol. 74, no. 3, pp. 1000–1007, 2000.
View at: Google Scholar
S A Howard, A Y Nakayama, S M Brooke et al., “Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures,” Experimental Neurology, vol. 158, no. 1, pp. 164–170, 1999.
View at: Google Scholar
J R Berger and A Nath, “HIV dementia and the basal ganglia,” Intervirology, vol. 40, no. 2-3, pp. 122–131, 1997.
View at: Google Scholar
L Hudson, J Liu, A Nath et al., “Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues,” Journal of Neurovirology, vol. 6, no. 2, pp. 145–155, 2000.
View at: Google Scholar
II Kruman, A Nath, W F Maragos et al., “Evidence that Par-4 participates in the pathogenesis of HIV encephalitis,” The American Journal of Pathology, vol. 155, no. 1, pp. 39–46, 1999.
View at: Google Scholar
T O Price, N Ercal, R Nakaoke et al., “HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells,” Brain Research, vol. 1045, no. 1-2, pp. 57–63, 2005.
View at: Google Scholar
A Nath, C Anderson, M Jones et al., “Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia,” Journal of Psychopharmacology, vol. 14, no. 3, pp. 222–227, 2000.
View at: Google Scholar
J A Gurwell, A Nath, Q Sun et al., “Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro,” Neuroscience, vol. 102, no. 3, pp. 555–563, 2001.
View at: Google Scholar
C Power, J C McArthur, A Nath et al., “Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients,” Journal of Virology, vol. 72, no. 11, pp. 9045–9053, 1998.
View at: Google Scholar
G J Wang, L Chang, N D Volkow et al., “Decreased brain dopaminergic transporters in HIV-associated dementia patients,” Brain, vol. 127, no. 11, pp. 2452–2458, 2004.
View at: Google Scholar
W E Muller, G Pergande, H Ushijima et al., “Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention,” Progress in Molecular and Subcellular Biology, vol. 16, pp. 44–57, 1996.
View at: Google Scholar
K K Jain, “Evaluation of memantine for neuroprotection in dementia,” Expert opinion on Investigational Drugs, vol. 9, no. 6, pp. 1397–1406, 2000.
View at: Google Scholar
C C Chao, S Hu, G Gekker et al., “U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression,” Neuropharmacology, vol. 39, no. 1, pp. 150–160, 2000.
View at: Google Scholar
D R Wallace, S L Dodson, A Nath et al., “Delta opioid agonists attenuate ${\text{TAT}}_{1 - 72}$ -induced oxidative stress in SK-N-SH cells,” NeuroToxicology, vol. 27, no. 1, pp. 101–107, 2006.
View at: Google Scholar
D R Wallace, S Dodson, A Nath et al., “Estrogen attenuates gp120- and ${\text{tat}}_{1 - 72}$ -induced oxidative stress and prevents loss of dopamine transporter function,” Synapse, vol. 59, no. 1, pp. 51–60, 2006.
View at: Google Scholar
S A Howard, S M Brooke, and R M Sapolsky, “Mechanisms of estrogenic protection against gp120-induced neurotoxicity,” Experimental Neurology, vol. 168, no. 2, pp. 385–391, 2001.
View at: Google Scholar
I Zemlyak, S M Brooke, and R M Sapolsky, “Protection against gp120-induced neurotoxicity by an array of estrogenic steroids,” Brain Research, vol. 958, no. 2, pp. 272–276, 2002.
View at: Google Scholar
L Pulliam, I Irwin, L Kusdra et al., “CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation,” Brain Research, vol. 893, no. 1-2, pp. 95–103, 2001.
View at: Google Scholar
D B Clifford, J C McArthur, G Schifitto et al., “A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment,” Neurology, vol. 59, no. 10, pp. 1568–1573, 2002.
View at: Google Scholar
J B Johnston, K Zhang, C Silva et al., “HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors,” Annals of Neurology, vol. 49, no. 2, pp. 230–241, 2001.
View at: Google Scholar
I P Everall, C Bell, M Mallory et al., “Lithium ameliorates HIV-gp120-mediated neurotoxicity,” Molecular and Cellular Neurosciences, vol. 21, no. 3, pp. 493–501, 2002.
View at: Google Scholar
J Turchan, C B Pocernich, C Gairola et al., “Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants,” Neurology, vol. 60, no. 2, pp. 307–314, 2003.
View at: Google Scholar
C B Pocernich, R Sultana, E Hone et al., “Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes,” Journal of Neuroscience Research, vol. 77, no. 4, pp. 532–539, 2004.
View at: Google Scholar
C B Pocernich, R Sultana, A H Mohmmad, A Nath, and D A Butterfield, “HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations,” Brain Research. Brain Research Reviews, vol. 50, no. 1, pp. 14–26, 2005.
View at: Google Scholar
R L Nosheny, I Mocchetti, and A Bachis, “Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration,” Neurotox Research, vol. 8, no. 1-2, pp. 187–198, 2005.
View at: Google Scholar

Copyright

Copyright © 2006 David R. Wallace. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

362

Downloads

782

Citations